Journal of Clinical Endocrinology & Metabolism, Vol 74, 525-532, Copyright © 1992 by Endocrine Society

ARTICLES

The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration

P D'Amour, J Palardy, G Bahsali, LE Mallette, A DeLean and R Lepage
Centre de Recherche Clinique Andre-Viallet, Hopital St-Luc, Institut de Recherches Cliniques de Montreal, Canada.

Twenty normal individuals received 2-h iv infusions of CaCl2 and Na2 ethylenediamine tetra-acetate, with sampling every 15 min. PTH was measured by means of an intact hormone assay (I) and two carboxylterminal assays structured to react mostly with mid (M) or late (L) carboxylterminal fragments. A mathematical model was used to fit the sigmoidal relationship between ionized calcium (CA++) and PTH values. The influence of Ca++ on circulating PTH immunoheterogeneity was assessed via changes in L/I, M/I, and M/L ratios. Results are reported as means +/- SD. Response to hypocalcemia was highest with M (57.8 +/- 26.4 pmol/L, P less than 0.005 vs. L or I) and higher with L (20.1 +/- 5.6 pmol/L; P less than 0.0005 vs. I) than with I (14.1 +/- 6.4 pmol/L). L/I, M/I, and M/L decreased from 2.43 +/- 0.56 to 1.54 +/- 0.19 (P less than 0.0005), 8.44 +/- 2.38 to 4.36 +/- 4.07 (P less than 0.0005), and 3.49 +/- 0.71 to 2.86 +/- 0.76 (P less than 0.005), respectively, during Na2 ethylenediamine tetra-acetate infusion. Nonsuppressible PTH was again higher with M (13.7 +/- 4.8 pmol/L; P less than 0.0005 vs. L or I) and higher with L (2.8 +/- 0.7 pmol/L, P less than 0.0005 vs. I) than with I (0.5 +/- 0.3 pmol/L). L/I, M/I, and M/L ratios increased from 2.47 +/- 0.97 to 5.35 +/- 2.09 (P less than 0.0005), 8.90 +/- 3.10 to 29.56 +/- 14.89 (P less than 0.0005), and 3.62 +/- 0.90 to 5.30 +/- 1.91 (P less than 0.005) during CaCl2 infusion. The set-point for PTH stimulation by calcium was similar for M (1.15 +/- 0.035 mmol/L) and L (1.175 +/- 0.041 mmol/L) but significantly higher with the I assay (1.184 +/- 0.31 mmol/L; P less than 0.0005 vs. M). The M/I, L/I, and M/L ratio set-points were similar at 1.28 +/- 0.01, 1.27 +/- 0.01, and 1.29 +/- 0.02 mmol/L. Thus, even if proportionately more intact PTH and less carboxylterminal fragments are produced and secreted during hypocalcemia, the latter still predominate in the circulation. Furthermore, at high calcium values, secretion of fragments is less well inhibited than that of intact hormone. The lower secretion and higher ratio set-points suggest that the secretion and intracellular degradation of PTH have different sensitivities to inhibition by calcium.

This article has been cited by other articles:

				A. J. Felsenfeld, M. Rodriguez, and E. Aguilera-Tejero Dynamics of Parathyroid Hormone Secretion in Health and Secondary Hyperparathyroidism Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1283 - 1305. [Abstract] [Full Text] [PDF]

				L. M. Henrich, A. D. Rogol, P. D'Amour, M. A. Levine, J. B. Hanks, and D. E. Bruns Persistent Hypercalcemia After Parathyroidectomy in an Adolescent and Effect of Treatment With Cinacalcet HCl Clin. Chem., December 1, 2006; 52(12): 2286 - 2293. [Abstract] [Full Text] [PDF]

				P. A. Friedman and W. G. Goodman PTH(1-84)/PTH(7-84): a balance of power Am J Physiol Renal Physiol, May 1, 2006; 290(5): F975 - F984. [Abstract] [Full Text] [PDF]

				T. Kawata, Y. Imanishi, K. Kobayashi, N. Onoda, Y. Takemoto, H. Tahara, S. Okuno, E. Ishimura, T. Miki, T. Ishikawa, et al. Direct in Vitro Evidence of Extracellular Ca2+-Induced Amino-Terminal Truncation of Human Parathyroid Hormone (1-84) by Human Parathyroid Cells J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5774 - 5778. [Abstract] [Full Text] [PDF]

				T. M. Murray, L. G. Rao, P. Divieti, and F. R. Bringhurst Parathyroid Hormone Secretion and Action: Evidence for Discrete Receptors for the Carboxyl-Terminal Region and Related Biological Actions of Carboxyl- Terminal Ligands Endocr. Rev., February 1, 2005; 26(1): 78 - 113. [Abstract] [Full Text] [PDF]

				J. J. Kazama, K. Omori, N. Higuchi, N. Takahashi, Y. Ito, H. Maruyama, I. Narita, T. L. Cantor, P. Gao, and F. Gejyo Intact PTH assay overestimates true 1-84 PTH levels after maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism Nephrol. Dial. Transplant., April 1, 2004; 19(4): 892 - 897. [Abstract] [Full Text] [PDF]

				M. Inaba, K. Nakatsuka, Y. Imanishi, M. Watanabe, Y. Mamiya, E. Ishimura, and Y. Nishizawa Technical and Clinical Characterization of the Bio-PTH (1-84) Immunochemiluminometric Assay and Comparison with a Second-Generation Assay for Parathyroid Hormone Clin. Chem., February 1, 2004; 50(2): 385 - 390. [Abstract] [Full Text] [PDF]

				Q. Chen, H. Kaji, M.-F. Iu, R. Nomura, H. Sowa, M. Yamauchi, T. Tsukamoto, T. Sugimoto, and K. Chihara Effects of an Excess and a Deficiency of Endogenous Parathyroid Hormone on Volumetric Bone Mineral Density and Bone Geometry Determined by Peripheral Quantitative Computed Tomography in Female Subjects J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4655 - 4658. [Abstract] [Full Text] [PDF]

				J. C. Estepa, I. Lopez, A. J. Felsenfeld, P. Gao, T. Cantor, M. Rodriguez, and E. Aguilera-Tejero Dynamics of secretion and metabolism of PTH during hypo- and hypercalcaemia in the dog as determined by the 'intact' and 'whole' PTH assays Nephrol. Dial. Transplant., June 1, 2003; 18(6): 1101 - 1107. [Abstract] [Full Text] [PDF]

				W. G. Goodman, I. B. Salusky, and H. Juppner New lessons from old assays: parathyroid hormone (PTH), its receptors, and the potential biological relevance of PTH fragments Nephrol. Dial. Transplant., October 1, 2002; 17(10): 1731 - 1736. [Full Text] [PDF]

				D. Nakaoka, T. Sugimoto, T. Kobayashi, T. Yamaguchi, A. Kobayashi, and K. Chihara Prediction of Bone Mass Change after Parathyroidectomy in Patients with Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1901 - 1907. [Abstract] [Full Text]

				J.-H. Brossard, R. Lepage, H. Cardinal, L. Roy, L. Rousseau, C. Dorais, and P. D'Amour Influence of Glomerular Filtration Rate on Non-(1-84) Parathyroid Hormone (PTH) Detected by Intact PTH Assays Clin. Chem., May 1, 2000; 46(5): 697 - 703. [Abstract] [Full Text] [PDF]

				R. Lepage, G. Légaré, C. Racicot, J.-H. Brossard, R. Lapointe, M. Dagenais, and P. D’Amour Hypocalcemia Induced during Major and Minor Abdominal Surgery in Humans J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2654 - 2658. [Abstract] [Full Text]

				H. Cardinal, J.-H. Brossard, L. Roy, R. Lepage, L. Rousseau, and P. D’Amour The Set Point of Parathyroid Hormone Stimulation by Calcium Is Normal in Progressive Renal Failure J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3839 - 3844. [Abstract] [Full Text]

				G. El-Hajj Fuleihan, J. Seifter, J. Scott, and E. M. Brown Calcium-Regulated Renal Calcium Handling in Healthy Men: Relationship to Sodium Handling J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2366 - 2372. [Abstract] [Full Text]